Compositions and methods for inhibiting expression of a gene from the Ebola virus

US9187516B2 · kind B2 · utility

Assignees

• Alnylam Pharmaceuticals, Inc. · US
• The United States of America as represented by the Secretary of the Army · US

Inventors

• Sina Bavari · Dillsburg, US
• Kelly Lyn Warfield · Adamstown, US
• Pamela Tan · Kulmbach, DE
• Anna Borodovsky · Cambridge, US
• Tatiana Novobrantseva · Cambridge, US
• Antonin de Fougerolles · Waterloo, BE

Key dates

• Filing date: May 15, 2014
• Grant date: Nov 17, 2015
• Expiry date: May 15, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/3531
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.